Teva Pharmaceutical Industries Lt.../ US8816242098 /
08/10/2024 18:56:56 | Chg. +0.17 | Volume | Bid18:57:00 | Ask18:57:00 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
17.45USD | +0.95% | 1.42 mill. Turnover: 21.74 mill. |
17.44Bid Size: 800 | 17.45Ask Size: 1,900 | -USD | - | - |
Assets
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 5,947 | 6,315 | 6,635 | 6,535 | 6,544 | ||||||
Intangible Assets | 10,316 | 7,745 | 6,476 | 5,512 | 7,675 | ||||||
Long-Term Investments | - | - | - | - | - | ||||||
Fixed Assets | - | - | - | - | - | ||||||
Inventories | 5,012 | 5,502 | 5,053 | 4,371 | 3,966 | ||||||
Accounts Receivable | 6,213 | 5,572 | 5,338 | 5,408 | 5,350 | ||||||
Cash and Cash Equivalents | 1,096 | 2,879 | 1,038 | 2,226 | 6,946 | ||||||
Current Assets | 14,453 | 16,355 | 13,720 | 14,396 | 18,398 | ||||||
Total Assets | 50,142 | 50,609 | 47,508 | 46,420 | 54,258 |
Liabilities
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 3,743 | 3,376 | 3,317 | 3,171 | 3,594 | ||||||
Long-term debt | - | - | - | - | - | ||||||
Liabilities to Banks | 4,280 | 3,006 | 1,804 | 1,761 | 1,585 | ||||||
Provisions | 2,610 | 1,849 | 1,247 | 1,101 | 1,748 | ||||||
Liabilities | 27,799 | 27,742 | 24,872 | 23,065 | 24,331 | ||||||
Share Capital | 50 | 50 | 50 | 50 | 52 | ||||||
Total Equity | 22,195 | 22,768 | 22,565 | 23,313 | 29,769 | ||||||
Minority Interests | 148 | 99 | 71 | 42 | 158 | ||||||
Total liabilities equity | 50,142 | 50,609 | 47,508 | 46,420 | 54,258 |
Income Statement
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 18,312 | 20,317 | 20,314 | 20,272 | 19,652 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | 3,109 | 2,205 | 1,649 | 3,951 | 3,352 | ||||||
Interest Income | -153 | -386 | -399 | -313 | -1,000 | ||||||
Income Before Taxes | 2,956 | 1,819 | 1,250 | 3,638 | 2,352 | ||||||
Income Taxes | 127 | -137 | -43 | 591 | 634 | ||||||
Minority Interests Profit | -9 | 53 | 16 | 13 | -9 | ||||||
Net Income | 2,759 | 1,963 | 1,269 | 3,055 | 1,588 |
Per Share
Cash Flow
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 4,134 | 4,572 | 3,237 | 5,127 | 5,542 | ||||||
Cash Flow from Investing Activities | -7,601 | -1,134 | -1,147 | -1,450 | -5,565 | ||||||
Cash Flow from Financing | 3,336 | -1,678 | -3,883 | -2,375 | 4,805 | ||||||
Decrease / Increase in Cash | -152 | 1,783 | -1,841 | 1,188 | 4,720 | ||||||
Employees | 45,754 | 45,948 | 44,945 | 43,000 | 32,866 |